Table of Contents
Fighting the stigma: Rising awareness of eating disorders will boost demand for clinics
Eating Disorder Clinics
The Eating Disorder Clinics industry has experienced robust consumer demand for industry services. While there has been a relatively high prevalence of eating disorders, few individuals with anorexia, bulimia and binge eating disorders actually receive treatment from industry clinics. many public and private health insurers either limit their coverage of eating disorder treatments or exclude it altogether. As a result, patients may experience significant impediments to receiving insurance coverage of services administered by eating disorder clinics, dampening industry revenue growth. While healthcare reform requires private insurers to provide mental health coverage as an essential health benefit, it does not explicitly require insurers to cover eating disorders. However, over the next five years, many states will likely continue expanding their mental health parity laws, including coverage for eating disorders, benefiting the industry.
This industry includes establishments devoted to the diagnosis and care of outpatients with disorders that affect, disrupt or more generally involve eating. Common eating disorders include anorexia nervosa, bulimia nervosa and binge eating. Industry operators are often associated with hospitals or medical schools as treatments for eating disorders usually involve psychotherapy, nutrition education, family counseling, medications and hospitalization.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Primary Care Doctors in the US
Mental Health & Substance Abuse Clinics in the US
Emergency & Other Outpatient Care Centers in the US
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Anorexia Nervosa Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H2, 2016" provides an overview of Anorexia Nervosa ...
Bulimia Nervosa Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Bulimia Nervosa Global Clinical Trials Review, H2, 2016" provides an overview of Bulimia Nervosa clinical ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...